Famciclovir: review of clinical efficacy and safety

This publication has 32 references indexed in Scilit:

• Acyclic Guanosine Analogs Inhibit DNA Polymerases .alpha., .delta., and .epsilon. with Very Different Potencies and Have Unique Mechanisms of Action
  Biochemistry, 1995
• Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients
  International Journal of Antimicrobial Agents, 1994
• Pharmacokinetics of Famciclovir in Subjects with Chronic Hepatic Disease
  The Journal of Clinical Pharmacology, 1994
• Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents
  Antiviral Research, 1994
• A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes Zoster
  New England Journal of Medicine, 1994
• Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers
  Journal of Antimicrobial Chemotherapy, 1994
• Shingles. Sorrows, salves, and solutions
  JAMA, 1993
• Use of isotopically chiral [4?-13C]penciclovir and13C NMR to determine the specificity and absolute configuration of penciclovir phosphate esters formed in HSV-1- and HSV-2-infected cells and by HSV-1-encoded thymidine kinase
  Chirality, 1993
• Use of isotopically chiral [4′‐¹³C]famciclovir and ¹³C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract
  Chirality, 1993
• Herpes zoster and postherpetic neuralgia
  Pain, 1986